Rise in the incidences of chronic degenerative diseases with aging makes wound care a
socio-economic burden and unceasingly necessitates a novel, economical, and efficient …

Stem cell therapy is widely recognized as a promising strategy for exerting therapeutic
effects after injury in degenerative diseases. However, limitations such as low cell retention …

Platelets are known to enhance the wound-healing activity of mesenchymal stem cells
(MSCs). However, the mechanism by which platelets improve the therapeutic potential of …

Ischemic diseases are characterized by reduced blood supply to a tissue or an organ due to
obstruction of blood vessels. The most serious and most common ischemic diseases include …

Background/aim Bone marrow mesenchymal stem cell (BMSC)-derived exosomes can
prevent oxidative stress and inflammation in cerebral ischemia-reperfusion injury. This study …

Stroke, a global disease with a high disability rate, has limited options for functional
rehabilitation and results in an adverse impact on patients' lives. In recent years …

Over the past decade, the growing interest in targeted lung cancer therapy has guided
researchers toward the cutting edge of controlled drug delivery, particularly magnetic …

Peripheral arterial disease is atherosclerotic occlusive disease of the lower extremity
arteries and afflicts hundreds of millions of individuals worldwide. Its most severe …

Critical limb ischemia (CLI), the terminal stage of peripheral arterial disease (PAD), is
characterized by an extremely high risk of amputation and vascular issues, resulting in …

Ischemic stroke is the leading cause of mortality and long-term disability worldwide.
Disruption of the blood–brain barrier (BBB) is a prominent pathophysiological mechanism …